Xiaoyong Fu
Title
Cited by
Cited by
Year
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
KL Meerbrey, G Hu, JD Kessler, K Roarty, MZ Li, JE Fang, JI Herschkowitz, ...
Proceedings of the National Academy of Sciences 108 (9), 3665-3670, 2011
4942011
Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast
J Zhang, X Shi, Y Li, BJ Kim, J Jia, Z Huang, T Yang, X Fu, SY Jung, ...
Molecular cell 31 (1), 143-151, 2008
3962008
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
CJ Creighton, X Fu, BT Hennessy, AJ Casa, Y Zhang, ...
Breast cancer research 12 (3), 1-12, 2010
2562010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
CJ Creighton, X Fu, BT Hennessy, AJ Casa, Y Zhang, ...
Breast cancer research 12 (3), 1-12, 2010
2562010
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers-role of estrogen receptor and HER2 reactivation
YC Wang, G Morrison, R Gillihan, J Guo, RM Ward, X Fu, MF Botero, ...
Breast Cancer Research 13 (6), 1-19, 2011
2322011
An epigenomic approach to therapy for tamoxifen-resistant breast cancer
Q Feng, Z Zhang, MJ Shea, CJ Creighton, C Coarfa, SG Hilsenbeck, ...
Cell research 24 (7), 809-819, 2014
1582014
Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance
XY Fu, HY Wang, L Tan, SQ Liu, HF Cao, MC Wu
World journal of gastroenterology 8 (4), 638, 2002
1232002
Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI (3, 4, 5) P3 production
Y Zhang, CC Tseng, YL Tsai, X Fu, R Schiff, AS Lee
PloS one 8 (11), e80071, 2013
1162013
Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma
H Li, X Fu, Y Chen, Y Hong, Y Tan, H Cao, M Wu, H Wang
Gastroenterology 128 (7), 2029-2041, 2005
1152005
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
X Fu, R Jeselsohn, R Pereira, EF Hollingsworth, CJ Creighton, F Li, ...
Proceedings of the National Academy of Sciences 113 (43), E6600-E6609, 2016
872016
Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer
X Fu, CK Osborne, R Schiff
The Breast 22, S12-S18, 2013
842013
Upregulation of ER signaling as an adaptive mechanism of cell survival in HER2-positive breast tumors treated with anti-HER2 therapy
M Giuliano, H Hu, YC Wang, X Fu, A Nardone, S Herrera, S Mao, ...
Clinical Cancer Research 21 (17), 3995-4003, 2015
662015
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or …
X Fu, CJ Creighton, NC Biswal, V Kumar, M Shea, S Herrera, A Contreras, ...
Breast Cancer Research 16 (5), 1-17, 2014
652014
Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance
N Putluri, S Maity, R Kommagani, CJ Creighton, V Putluri, F Chen, ...
Neoplasia 16 (5), 390-402, 2014
602014
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
R Jeselsohn, MI Cornwell, M Pun, G Buchwalter, M Nguyen, C Bango, ...
Proceedings of the National Academy of Sciences 114 (22), E4482-E4491, 2017
592017
RFWD3–Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage
X Fu, N Yucer, S Liu, M Li, P Yi, JJ Mu, T Yang, J Chu, SY Jung, ...
Proceedings of the National Academy of Sciences 107 (10), 4579-4584, 2010
592010
PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells
G Buchwalter, MM Hickey, A Cromer, LM Selfors, RN Gunawardane, ...
Cancer cell 23 (6), 753-767, 2013
522013
Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2–ERα–GREB1 Transcriptional Axis
Y Wu, Z Zhang, ME Cenciarini, CJ Proietti, M Amasino, T Hong, M Yang, ...
Cancer research 78 (3), 671-684, 2018
492018
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
G Morrison, X Fu, M Shea, S Nanda, M Giuliano, T Wang, T Klinowska, ...
Breast cancer research and treatment 144 (2), 263-272, 2014
462014
SGK3 is associated with estrogen receptor expression in breast cancer
J Xu, M Wan, Q He, RL Bassett, X Fu, AC Chen, F Shi, CJ Creighton, ...
Breast cancer research and treatment 134 (2), 531-541, 2012
462012
The system can't perform the operation now. Try again later.
Articles 1–20